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nderwent HBeAg loss and seroconversion to anti e. Loss of
BsAg was documented in 1 patient. HBV-DNA follow up was
vailable in 17/19 patients (2/19 pending). 13/17 achieved
BV-DNA undetectability (mean 58 weeks). 4/17 reduced
heir HBV-DNA by a mean of 4.75 log (range: 3.1 to 6.2 log)
ith a mean follow up of 33 weeks. Among 13 patients who
ad abnormal ALT at baseline, 9 normalized during the fol-
ow up. Among patients previously experienced with 3TC:
achieved undetectable HBV DNA and the other decreased
.2 log from baseline.
Conclusion: As pointed out by the international litera-
ure, we found a high virological and biochemical efﬁcacy of
DF in HIV-HBV co-infected patients, in terms of HBV antivi-
al inhibition in both previously treated with 3TC and naive
atients.
oi:10.1016/j.ijid.2010.02.517
8.012
n assessment of the seroprevalence of hepatitis A anti-
ody and vaccination among HIV patients in an inner city
IV clinic
. Adejumo ∗, V. Sivapalan, S. Mannheimer
Columbia University College Of Physicians and Surgeons
fﬁliation at Harlem Hospital Center, New York, NY, USA
Background: Routine hepatitis A virus (HAV) screening
nd vaccination is recommended in the guidelines for the
anagement of high risk persons infected with the human
mmunodeﬁciency virus (HIV). Scientiﬁc evidence shows that
atients with no immunity against HAV suffer prolonged
linical course and hepatitis related liver abnormalities if
nfected with acute hepatitis when compared to those who
ave immunity. The objective of this study is to assess
he seroprevalence of anti-HAV and hepatitis A vaccination
mong high risk patients in the outpatient HIV clinic.
Methods: A retrospective review of medical records of
igh risk adult patients (age > 18y) who attended the outpa-
ient HIV clinic between the period of July 2007 - December
008. The clinic provides primary care services to approxi-
ately 750 HIV-infected patients. The clinic demographics
nclude 47% women, 83% Blacks and 14% Latinos.
Results: 244 high risk HIV infected adult patients had at
east one visit within the study period. All received anti-
AV screening, of which 87.3% (n=213) tested negative for
nti-HAV and 12.7% (n=31) tested positive. Among those who
ested negative, 12% (n=26) had only 1 visit and did not fol-
ow up. Of the remaining 187 patients who followed up, 60%
n=113) received at least 1 dose of hepatitis A vaccine and
0% (n=74) did not receive a single dose of vaccine. Among
he total 244 patients, 18 had perinatally acquired HIV infec-
ion. 88% (n=16) of these patients with perinatal HIV had
ositive anti-HAV and are responsible for 52% of the total
1 patients with positive antibody. All the 31 patients with
nti-HAV had more than 1 visit.
Conclusion: In our cohort of high risk HIV infected adults,
atients with perinatal HIV are more likely to have anti-HAV.
he seroprevalence of anti-HAV in our chort is low (12.7%)
nd similar to the rate reported in other studies. The hep-
titis A vaccination rate of 60% in our cohort is below the
arget of greater than 90% vaccination rate needed for herd
a
dternational Congress on Infectious Diseases (ICID) Abstracts
mmunity to lessen the impact of the disease in the com-
unity. The high rate of anti-HAV in patients with perinatal
IV highlights the effectiveness of the strategy for child-
ood hepatitis A vaccination schedule. Comparable success
n adult patients will require a higher adherence to vaccina-
ion recommendations in order to prevent HAV infection in
IV patients.
oi:10.1016/j.ijid.2010.02.518
8.013
entral nervous system opportunistic infections (CNS-OI)
n HIV-infected children from Buenos Aires, Argentina
. Fallo ∗, A. de Mena, L. Torrado, N. Sordelli, G.
anonelles, E.L. Lopez
Hospital de Nin˜os ‘‘Ricardo Gutiérrez’’, Buenos Aires,
rgentina
Background: CNS-OI is a frequent event in adult AIDS
atients (pts) with decreasing rates in the HAART era. The
pectrum of CNS disease is quite different in paediatric AIDS
nd there are very few reports about the incidence rates
f CNS-OI in children. The objective was to describe the
linical course and outcome risk of CNS-OI in a perinatally
IV-infected cohort from Argentina.
Methods: Retrospective study among 397 HIV infected
hildren followed-up from 1998-2008. All pts with conﬁrmed
NS-OI infection were included. Pts with congenital infec-
ions, other neurological disorders or without an etiologic
gent identiﬁed were excluded.
Results: Out of 397 pts, 23 (6%) developed 24 CNS OI
uring follow-up (0.8/100 personyears). Bacterial meningitis
BM) 6 (25%), which were N meningitidis 2, St. pneumoniae
, St. agalactiae 1 and L monocytogenes 1. TB 5 (21%), C neo-
ormans (Crypto) 4 (17%), toxoplasmosis 2 (8%), JCV 2 (8%),
AI 1 (4%), CMV 1 (4%), EBV-CNS lymphoma 1(4%), measles
SPE 1 (4%). Common initial symptoms were fever (61%),
eurological deﬁcits (26%) and headache (22%).
At diagnosis of OI, mean age: 7.6 ± 6 years, mean CD4:
5 ± 14%, mean viral load: 4.8 ± 1 log.
CNS OI was the ﬁrst manifestation of HIV in 6 pts (26%);
7 were on HAART, 11 of them (48%) had poor adherence.
o IRIS was assumed.
BM and TB were more prevalent in the youngest pts
median age: 5 vs 12 years. p=0.03). Median CD4% of BM
as higher than the rest (30 vs 5 p=0.007)
Neurological sequelaes were present in 6. Six pts died
26%). Causes of death were 1 TB, 1 MAI, 1 JCV, 1 EBV-
ymphoma, 1 CMV and 1 Crypto. CNS-OI mortality was higher
han in the rest of pts, 6/23 vs 31/374 (p=0.01) and KM
urvival log rank p=0.03.
Conclusion: In developing countries OI are still prevalent,
specially in pts with late diagnosis of HIV, poor adherence
r advanced AIDS disease. In this series, a signiﬁcant high
ortality was observed. BM and TB were more prevalent in
ounger children. In older children, the spectrum was more
imilar to adults and the relation with low CD4 was more
ccurate.
oi:10.1016/j.ijid.2010.02.519
